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D De ea ar r   S Si ir rs s, ,   
Ocular metastases of solid tumors are very rare,
but in most of them (~45-70% of all detected ocular
metastases) the primary site of origin is the breast [1,
2].  Ocular  metastases  of  breast  cancer  appear
frequently without previous dissemination to organs
even those in close proximity. Thus, occurrence of
ocular metastases may be the characteristic feature
of a special subgroup of breast cancers. Herein, we
decided to analyse whether breast cancers with
associated ocular metastases belong to a group of
cancers constituting a specific part of a subset of
breast cancer family syndromes. 
We investigated a series of 15 breast cancer patients
with ocular metastases, detected in 1998-2002 by
ophthalmologists in Szczecin (10 of 15) and Poznañ (5
of 15). The distinction between breast cancer metastases
and primary ocular tumours was based on results of
routine ophthalmological examination supported in
most cases by angiography, ultrasonography, computer
tomography and magnetic resonance imaging. Tumours
were  verified  pathologically  (aspiration  biopsy  or
surgical section) in 3 cases. In all three cases the
metastatic character of the tumour was confirmed. In
all 15 cases, age at diagnosis and pedigree data on
the occurrence of cancers among first and second
degree relatives was collected. In 11 of 15 cases
peripheral  blood  lymphocyte  DNA  for  mutations
analyses were available. A search for the most common
Polish BRCA1 gene mutations (5382insC, C61G and
4153delA) was performed as described by Górski et al
(2000). This test can detect around 90% of all BRCA1
mutation carriers in the Polish population [3]. The
presence of BRCA2 mutations was also investigated by
full sequencing of coding regions of this gene [4]. 
Familial  aggregation  of  breast  cancers  (one,
additional to the proband, breast cancer patient
among first degree relatives) was found in only one
family. No patient with BRCA1 constitutional mutation
was identified. BRCA2 mutations (3562 A/G and 9079
G/A) were detected in two patients. The remaining 12
patients  did  not  present  with  any  other  unusual
characteristics apart from early disease onset. In 10 of
12 cases, breast cancers have been diagnosed under
51 years of age (27, 29, 29, 36, 40, 41, 42, 42, 44,
50). Only in the case of two patients cancers were
diagnosed in other first degree relatives (pancreatic
cancer diagnosed at the age of 58 and endometrial
cancer diagnosed at the age of 68). 
Histopathology was not verified in this set of breast
cancer patients, but multifocal disease was reported
in 3 of 10 non-familial, non-BRCA1/2 mutation early
onset cases. Furthermore, only one of them was
reported  to  be  a lobular  type;  all  others  were
diagnosed as ductal cancers. 
Our observation has several limitations: the studied
series is small, not all metastatic tumours have been
verified histopathologically and more precise data
about the pathologic and molecular features of breast
cancers is required. 
Nevertheless,  this  small  study  shows  that  the
characteristic features of breast cancers with ocular
metastases include early age at diagnosis and the lack
of familial aggregation of breast cancers and of
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The early onset of breast cancer in these cases
suggests a genetic predisposition and given the low
frequency of cancers among first degree relatives, this
predisposition might be a gene defect with recessive
inheritance, a ”de novo” dominant mutation, a complex
genetic  inheritance  that  does  not  follow  obvious
Mendelian inheritance (or possibly even an X-linked
mutation with expression in females only). 
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